Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PCV108 USE OF RENIN SYSTEM AGENTS AMONG HYPERTENSION PATIENTS WITH RENAL DISEASE IN A MANAED CARE SETTING

Autor: Stern, L, Lamerato, L, Ogbonnaya, A, Hwa Ong, S, Munk, VC, Charney, A

Publikováno v: In Value in Health 2009 12(3):A161-A161

PCV26 BELGIAN BUDGET IMPACT ANALYSES OF ALISKIREN (TEKTURNA/RASILEZ) IN HYPERTENSION

Autor: Lecomte, P, Lamotte, M, Esposito, G, Annemans, L, Kotchie, RW, Munk, VC, Vincze, G

Publikováno v: In Value in Health 2008 11(3):A193-A193

Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer.

Autor: Rosen VM; Optum, Eden Prairie, MN; †Mapi Group, Uxbridge; and ‡University College London Hospitals, London, UK; §Federal University, Belo Horizonte; and ∥State University of Campinas, Campinas, Brazil; and ¶F. Hoffmann-La Roche Ltd, Basel, Switzerland., Guerra I, McCormack M, Nogueira-Rodrigues A, Sasse A, Munk VC, Shang A

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2017 Jul; Vol. 27 (6), pp. 1237-1246.

Effects on blood pressure and cardiovascular risk of variations in patients' adherence to prescribed antihypertensive drugs: role of duration of drug action.

Autor: Lowy A; Novartis Pharma AG, Basel, Switzerland. adam.lowy@novartis.com, Munk VC, Ong SH, Burnier M, Vrijens B, Tousset EP, Urquhart J

Publikováno v: International journal of clinical practice [Int J Clin Pract] 2011 Jan; Vol. 65 (1), pp. 41-53. Date of Electronic Publication: 2010 Nov 22.